Clinical Trial Results:
A 12-week multicentre, double blind, double dummy, randomized, parallel group, active controlled study to evaluate the efficacy and tolerability of fluvastatin extended release (Lescol XL® 80 mg) alone or in combination with ezetimibe10 mg as compared to ezetimibe monotherapy, in dyslipidemic patients with previous history of muscular complaints with other statins
Summary
|
|
EudraCT number |
2004-004208-19 |
Trial protocol |
NO DE |
Global completion date |
23 Dec 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Jan 2017
|
First version publication date |
07 Jan 2017
|
Other versions |
|
Summary report(s) |
CXU0320B2406 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.